Anthropic Faces Drug Development Reality Check in Filing
Anthropic Faces Drug: Anthropic Tempers Bold Medical Claims in IPO Filing For months, Anthropic promised that artificial intelligence would fast-track medical science and rewrite drug development timelines. However, the company offered a much more measured view in its recent IPO filing submitted on Monday. Although CEO Dario Amodei previously suggested that models like Claude could … Read more